Arrhythmia News and Research

RSS

An arrhythmia is a problem with the speed or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. A heartbeat that is too fast is called tachycardia. A heartbeat that is too slow is called bradycardia. Most arrhythmias are harmless, but some can be serious or even life threatening. When the heart rate is too slow, too fast, or irregular, the heart may not be able to pump enough blood to the body. Lack of blood flow can damage the brain, heart, and other organs.

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).

23 May 2011

New book provides insight into new stem cell therapies for stabilizing heart function

A new book edited by researchers at Worcester Polytechnic Institute and the Stony Brook University School of Medicine provides a comprehensive look at the science and application of cellular therapies aimed at the leading cause of death---heart disease.

18 May 2011

Researchers discover quarky calcium release in heart cells

Three years of microscopic experiments on heart cells has led to a discovery by a team of University of Maryland researchers and collaborators of the workings of faint calcium signals in the heart cells, a discovery that may translate into new therapies for heart disease.

12 May 2011

MHI team uses cryoablation to successfully treat atrial fibrillation

The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.

From Medtronic 11 May 2011

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Cardiologists from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research at The Heart Rhythm Society's 32nd Annual Scientific Sessions, May 4 -7 in San Francisco, California.

9 May 2011

Urgent action needed to avoid preventable strokes in Asia-Pacific region, says new report

Experts from medical and patient communities call on national policymakers in the Asia-Pacific region to take urgent action against preventable strokes that strike millions of people with atrial fibrillation each year.

7 May 2011

Abiomed presents PROTECT II study data in percutaneous coronary intervention at SCAI 2011

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced results from further 90 day clinical and economic analyses, based on data from the PROTECT II study.

7 May 2011

New cardiac genetic testing guidelines for health care professionals

An international panel of experts from The Heart Rhythm Society and the European Heart Rhythm Association issued new guideline recommendations for all health care professionals about cardiovascular genetic testing at the Heart Rhythm Society's 32nd Annual Scientific Sessions.

7 May 2011

Lead investigator to discuss growing impact of AFib on US health care costs and resources

Two studies to be presented this week address the often-overlooked costs associated with atrial fibrillation, the most common form of cardiac arrhythmia.

5 May 2011

Cameron Health completes enrollment in subcutaneous implantable defibrillator pivotal study

Cameron Health, Inc. announced today that it has completed enrollment in its pivotal FDA clinical study of the S-ICD System, the world's only completely subcutaneous implantable defibrillator.

5 May 2011

Boston Scientific reports first use in Europe of Blazer Open-Irrigated Catheter

Boston Scientific Corporation today announced CE Mark approval and first use in Europe of its Blazer™ Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The product is being launched this quarter in select CE Mark countries.

4 May 2011

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Affymax, Inc. and Takeda Pharmaceutical Company Limited, today announced results of additional analyses from two Phase 3 studies of the investigational agent, peginesatide in chronic renal failure patients on dialysis with anemia.

29 Apr 2011

Global Health Partner revenues increase 27% to SEK 178.9 million

Global Health Partner: FIRST QUARTER 2011. Revenues increased by 27 percent to SEK 178.9 million.

28 Apr 2011

Bioengineering students invent life-saving heart device

An invention by Rice University bioengineering students in collaboration with the Texas Heart Institute is geared toward giving immediate second chances to arrhythmia victims headed toward cardiac arrest.

27 Apr 2011

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

The Government of Rwanda, together with QIAGEN N.V. and Merck, known as MSD outside the United States and Canada, today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.

From QIAGEN Manchester Limited 25 Apr 2011

Novation adds BIOTRONIK to Cardiac Rhythm Management Devices portfolio

Novation, the leading health care supply contracting company, announced today the addition of BIOTRONIK (Lake Oswego, OR) to its Cardiac Rhythm Management (CRM) Devices portfolio. This new 30-month agreement represents the first collaboration between the respective organizations.

22 Apr 2011

Cardiologist pioneers new test to detect sudden death syndrome in young athletes

When a high school athlete drops dead, the rare but fatal condition called "sudden death syndrome" dominates the headlines. For reasons that remain a mystery to scientists, some young athletes - especially young males - begin to experience an unusual heart arrhythmia. With over-exertion, their hearts stop pumping, leading to sudden death.

22 Apr 2011

New nonviral method to create cardiac cells

Johns Hopkins scientists have developed a simplified, cheaper, all-purpose method they say can be used by scientists around the globe to more safely turn blood cells into heart cells. The method is virus-free and produces heart cells that beat with nearly 100 percent efficiency, they claim.

11 Apr 2011

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.

8 Apr 2011

EKG test is a poor predictor of sudden death syndrome in young athletes

The sudden death of a young athlete always prompts full media attention, most recently spurring a call for preventative screening methods, including costly electrocardiogram tests for all school-age athletes.

6 Apr 2011

Arrhythmia News and Research

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

New book provides insight into new stem cell therapies for stabilizing heart function

Researchers discover quarky calcium release in heart cells

MHI team uses cryoablation to successfully treat atrial fibrillation

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Urgent action needed to avoid preventable strokes in Asia-Pacific region, says new report

Abiomed presents PROTECT II study data in percutaneous coronary intervention at SCAI 2011

New cardiac genetic testing guidelines for health care professionals

Lead investigator to discuss growing impact of AFib on US health care costs and resources

Cameron Health completes enrollment in subcutaneous implantable defibrillator pivotal study

Boston Scientific reports first use in Europe of Blazer Open-Irrigated Catheter

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Global Health Partner revenues increase 27% to SEK 178.9 million

Bioengineering students invent life-saving heart device

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Novation adds BIOTRONIK to Cardiac Rhythm Management Devices portfolio

Cardiologist pioneers new test to detect sudden death syndrome in young athletes

New nonviral method to create cardiac cells

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

EKG test is a poor predictor of sudden death syndrome in young athletes

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News